Immutep Statistics
Total Valuation
Immutep has a market cap or net worth of $245.05 million. The enterprise value is $176.79 million.
| Market Cap | 245.05M |
| Enterprise Value | 176.79M |
Important Dates
The next estimated earnings date is Wednesday, August 28, 2024, after market close.
| Earnings Date | Aug 28, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Immutep has 126.31 million shares outstanding.
| Shares Outstanding | 126.31M |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 2.43% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 7.65 |
| PS Ratio | 53.54 |
| Forward PS | 25.54 |
| PB Ratio | 3.17 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 38.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 17.24, with a Debt / Equity ratio of 0.01.
| Current Ratio | 17.24 |
| Quick Ratio | 16.75 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,499.08 |
Financial Efficiency
Return on equity (ROE) is -42.10% and return on invested capital (ROIC) is -34.40%.
| Return on Equity (ROE) | -42.10% |
| Return on Assets (ROA) | -38.60% |
| Return on Capital (ROIC) | -34.40% |
| Revenue Per Employee | $147,637 |
| Profits Per Employee | -$888,771 |
| Employee Count | 31 |
| Asset Turnover | 0.06 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.78% in the last 52 weeks. The beta is 1.90, so Immutep's price volatility has been higher than the market average.
| Beta (5Y) | 1.90 |
| 52-Week Price Change | -13.78% |
| 50-Day Moving Average | 2.56 |
| 200-Day Moving Average | 2.32 |
| Relative Strength Index (RSI) | 39.03 |
| Average Volume (20 Days) | 724,094 |
Short Selling Information
| Short Interest | 4.44M |
| Short Previous Month | 4.18M |
| Short % of Shares Out | 3.68% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 12.38 |
Income Statement
In the last 12 months, Immutep had revenue of $4.58 million and -$27.55 million in losses. Loss per share was -$0.26.
| Revenue | 4.58M |
| Gross Profit | 4.50M |
| Operating Income | -26.96M |
| Pretax Income | -27.07M |
| Net Income | -27.55M |
| EBITDA | n/a |
| EBIT | -27.06M |
| Loss Per Share | -$0.26 |
Balance Sheet
The company has $69.34 million in cash and $1.08 million in debt, giving a net cash position of $68.26 million or $0.54 per share.
| Cash & Cash Equivalents | 69.34M |
| Total Debt | 1.08M |
| Net Cash | 68.26M |
| Net Cash Per Share | $0.54 |
| Equity (Book Value) | 77.30M |
| Book Value Per Share | 0.61 |
| Working Capital | 71.17M |
Cash Flow
In the last 12 months, operating cash flow was -$28.00 million and capital expenditures -$16,137, giving a free cash flow of -$28.02 million.
| Operating Cash Flow | -28.00M |
| Capital Expenditures | -16,137 |
| Free Cash Flow | -28.02M |
| FCF Per Share | -$0.24 |
Margins
Gross margin is 98.25%, with operating and profit margins of -589.16% and -602.00%.
| Gross Margin | 98.25% |
| Operating Margin | -589.16% |
| Pretax Margin | -591.49% |
| Profit Margin | -602.00% |
| EBITDA Margin | n/a |
| EBIT Margin | -591.26% |
| FCF Margin | -612.12% |
Dividends & Yields
Immutep does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -58.70% |
| Shareholder Yield | -58.70% |
| Earnings Yield | -11.24% |
| FCF Yield | -11.43% |
Analyst Forecast
The average price target for Immutep is $8.00, which is 312.37% higher than the current price. The consensus rating is "Buy".
| Price Target | $8.00 |
| Price Target Difference | 312.37% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 73.88% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 28, 2016. It was a reverse split with a ratio of 3:10.
| Last Split Date | Dec 28, 2016 |
| Split Type | Reverse |
| Split Ratio | 3:10 |
Scores
Immutep has an Altman Z-Score of 22.93 and a Piotroski F-Score of 3.
| Altman Z-Score | 22.93 |
| Piotroski F-Score | 3 |